Skip to main content

Table 4 Stock levels of test kits, lancets, drugs and needles and syringes for HIV and syphilis testing and treatment

From: Rollout of rapid point of care tests for antenatal syphilis screening in Ghana: healthcare provider perspectives and experiences

Consumables Stock levels
Nil < 1 month ≥1 month
Test kits and lancets
 Syphilis test kits (n = 13)a 6 0 7
 Syphilis test kits-chase buffer (n = 13)a 6 1 6
 HIV test kits/diluent (n = 14)b 0 4 10
 Lancets (n = 15) 1 0 14
Drugs and needles and syringes
 Injection Benzathine penicillin (n = 13)a 8 1 6
 Tablets Erythromycin (n = 13)a 7 0 8
 Syrup Nevirapine (n = 8)c 0 2 6
 Tablets Sulphadoxine pyrimethamine (n = 15) 2 1 12
 Needles and syringes (n = 15) 1 0 14
  1. a2 facilities which had not started syphilis screening were excluded; b1 facility which had not started antenatal HIV screening was excluded; c7 facilities that were not offering antiretroviral therapy (nevirapine) to babies of HIV positive mothers and referred all babies to other facilities for treatment were excluded